Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Revolution Medicines (RVMD) Return on Sales: 2019-2025

Historic Return on Sales for Revolution Medicines (RVMD) over the last 4 years, with Sep 2025 value amounting to 89.92%.

  • Revolution Medicines' Return on Sales was N/A to 89.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 89.92%, marking a year-over-year change of. This contributed to the annual value of 237.36% for FY2024, which is 27504.00% up from last year.
  • Revolution Medicines' Return on Sales amounted to 89.92% in Q3 2025, which was up 168.43% from -131.42% recorded in Q4 2024.
  • Revolution Medicines' Return on Sales' 5-year high stood at 89.92% during Q3 2025, with a 5-year trough of -131.42% in Q4 2024.
  • Moreover, its 3-year median value for Return on Sales was -13.12% (2023), whereas its average is -21.73%.
  • In the last 5 years, Revolution Medicines' Return on Sales rose by 29bps in 2023 and then plummeted by 11,520bps in 2024.
  • Over the past 5 years, Revolution Medicines' Return on Sales (Quarterly) stood at -6.37% in 2021, then plummeted by 66bps to -7.03% in 2022, then tumbled by 919bps to -16.22% in 2023, then crashed by 11,520bps to -131.42% in 2024, then reached 89.92% in 2025.
  • Its last three reported values are 89.92% in Q3 2025, -131.42% for Q4 2024, and -55.21% during Q1 2024.